Evidence map›Paper›PMID 40141298›Full record

ArticleInternational journal of molecular sciences2025

A Probiotic Mixture of

Maria Raffaella Barbaro, Francesca Bianco, Cesare Cremon, Giovanni Marasco, Vincenzo Stanghellini, Giovanni Barbara

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Smart CaCOScientific reports · 2026
    Article
  5. DietaryInternational journal of molecular sciences · 2025
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maria Raffaella BarbaroIRCCS Azienda Ospedaliero-Universitaria di Bologna, I-40138 Bologna, Italy.
Francesca BiancoIRCCS Azienda Ospedaliero-Universitaria di Bologna, I-40138 Bologna, Italy.
Cesare CremonIRCCS Azienda Ospedaliero-Universitaria di Bologna, I-40138 Bologna, Italy.ORCID 0000-0002-7777-2936
Giovanni MarascoIRCCS Azienda Ospedaliero-Universitaria di Bologna, I-40138 Bologna, Italy.ORCID 0000-0001-7167-8773
Vincenzo StanghelliniIRCCS Azienda Ospedaliero-Universitaria di Bologna, I-40138 Bologna, Italy.ORCID 0000-0003-0559-4875
Giovanni BarbaraIRCCS Azienda Ospedaliero-Universitaria di Bologna, I-40138 Bologna, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Irritable Bowel Syndrome (IBS) is a disorder of gut- brain interaction characterized by recurrent abdominal pain associated with altered bowel habits. The therapeutic options for IBS patients include the use of probiotics. The aim of this study was to assess the effect of a multi-strain probiotic made up by

Indexed as

Bifidobacterium animalisBifidobacterium longumIntestinal MucosaIrritable Bowel SyndromeLacticaseibacillus rhamnosusProbioticsZonula Occludens-1 ProteinAdultCaco-2 CellsFemaleHumansMaleMiddle AgedPermeabilityTJP1 protein, humanZonula Occludens-1 Proteinirritable bowel syndromepermeabilityprobioticsZO-1

Identifiers

PMID40141298
PMCPMC11942538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.